Changes in Patterns of Coronary Revascularization Strategies for Patients With Acute Coronary Syndromes (from the CRUSADE Quality Improvement Initiative)

American Journal of Cardiology

Volumn 99, Issue 9, 2007, Pages 1222-1226

  Gogo Jr , Prospero B ^a   Dauerman, Harold L ^a   Mulgund, Jyotsna ^b   Ohman, E Magnus ^b   Patel, Manesh R ^b   Cohen, David J ^d   Saucedo, Jorge F ^e   Harrington, Robert A ^b   Gibler, W Brian ^f   Smith Jr , Sidney C ^c   Peterson, Eric D ^b   Roe, Matthew T ^b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC PATIENT; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HOSPITAL; HOSPITAL PATIENT; HUMAN; KIDNEY FAILURE; PATIENT CARE; PRIORITY JOURNAL; REVASCULARIZATION; UNITED STATES;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CORONARY ARTERY BYPASS; CORONARY DISEASE; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; SYNDROME; UNITED STATES;

EID: 34247483103     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.12.037     Document Type: Article

References (16)

1. Kandzari D.E., Roe M.T., Ohman E.M., Milford-Beland S., Chen A.Y., Lytle B.L., Cohen D.J., Smith S.C., Harrington R.A., Gibler W.B., and Peterson E.D. Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes. Am J Cardiol 96 (2005) 750-755
2. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335 (1996) 217-225
3. Niles N.W., McGrath P.D., Malenka D., Quinton H., Wennberg D., Shubrooks S.J., Tryzelaar J.F., Clough R., Hearne M.J., Hernandez Jr. F., Watkins M.W., O'Connor G.T., and Northern New England Cardiovascular Disease Study Group. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. J Am Coll Cardiol 37 (2001) 1008-1015
4. McGuire D.K., Anstrom K.J., and Peterson E.D. Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network Database. Circulation 107 (2003) 1864-1870
5. Liang K., and Zeger S. Longitudinal data analysis using generalized linear models. Biometrika 73 (1986) 13-22
6. Braunwald E., Antman E.M., Beasley J.W., Califf R.M., Cheitlin M.D., Hochman J.S., Jones R.H., Kereiakes D., Kupersmith J., Levin T.N., et al. American College of Cardiology; American Heart Association. Committee on the Management of Patients With Unstable Angina. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Unstable Angina). J Am Coll Cardiol 40 (2002) 1366-1374
7. Tricoci P., Mulgund J., Harrington R.A., Newby L.K., Saucedo J.F., Kleiman N.S., Bhatt D.L., Berger P., Cannon C.P., Cohen D.J., et al. Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE). Am J Cardiol 98 (2006) 1172-1176
8. Rao S.V., Shaw R.E., Brindis R.G., Klein L.W., Weintraub W.S., and Peterson E.D. On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR]). Am J Cardiol 97 (2006) 1478-1481
9. Joner M., Finn A.V., Farb A., Mont E.K., Kolodgie F.D., Ladich E., Kutys R., Skorija K., Gold H.K., and Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
10. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., et al. Incidence, predictors, and outcomes of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
11. Spaulding C., Henry P., Teiger E., Beatt K., Bramucci E., Carrie D., Slama M.S., Merkely B., Erglis A., Margheri M., et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355 (2006) 1093-1104
12. Laarman G.J., Suttorp M.J., Dirksen M.T., van Heerebeek L., Kiemenij F., Slagboom T., van der Wieken L.R., Tijssen J.G., Rensing B.J., and Patterson M. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 355 (2006) 1105-1113
13. Stone GW. DES evidence-based medicine: perspectives on emerging safety concerns, real world outcomes and use recommendations. Transcatheter Therapeutics 2006, October 2006. Available at: http://www.tctmd.com/csportal/appmanager/tctmd/main?_nfpb=true&_page Label=TCTMDContent&hdCon=1452671.
14. Spertus J.A., Kettelkamp R., Vance C., Decker C., Jones P.G., Rumsfeld J.S., Messenger J.C., Khanal S., Peterson E.D., Bach R.C., Krumholz H.M., and Cohen D.J. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug eluting stent placement-results from the PREMIER registry. Circulation 113 (2006) 2803-2809
15. Malenka D.J., Leavitt B.J., Hearne M.J., Robb J.F., Baribeau Y.R., Ryan T.J., Helm R.E., Kellett M.A., Dauerman H.L., Dacey L.J., et al. Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England. Circulation 112 suppl (2005) I371-I376
16. Serruys P.W., Ong A.T., van Herwerden L.A., Sousa J.E., Jatene A., Bonnier J.J., Schlonberger J.P., Buller N., Bonser R., Disco C., et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 46 (2005) 575-581